Skip to content

Multi-center random open-labeled parallel controlled trial for evaluating the effectiveness and safety of virtual-reality cognitive function rehabilitation software on cognitive functions for patients with mental disorder

Multi-center random open-labeled parallel controlled trial for evaluating the effectiveness and safety of virtual-reality cognitive function rehabilitation software on cognitive functions for patients with mental disorder

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022929
Enrollment
Unknown
Registered
2019-05-04
Start date
2019-05-06
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

????

Interventions

Experimental group:Rehabilitation with VR software
control group:none

Sponsors

First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 55 years old male or female; 2) ICD-10 diagnostic criteria for mental and behavioral disorders (including, but not limited to, schizophrenia, mood disorders, organic mental disorders); 3) Currently in the clinical symptom relief period; 4) The use of existing psychotropic drugs is allowed, and the therapeutic dose has been stable for more than one month; 5) Signing the informed consent form; 6) The number of years of education is = 6 years; 7) Vision or correct vision, right hand, can complete various experimental tests.

Exclusion criteria

Exclusion criteria: 1) Patients with medical history of cognitive decline (such as mental retardation, congenital genetic disease, hypoxic ischemic encephalopathy, brain trauma, etc.); 2) Patients with epilepsy, dizziness, stroke, vestibular dysfunction or other central nervous system diseases; 3) Critically ill patients or pregnant patients; 4) Patients that received electroconvulsive therapy in the past 1 year, and have a history of substance abuse and drug dependence in the past 30 days (except smoking); 5) Other training or medications to improve or promote cognition are currently being used; 6) VR use contraindications: (1) scalp trauma, extensive or open craniocerebral trauma, unable to place VR equipment; (2) unable to cooperate with the completion of the examination; 7) Patients participating in other clinical trials; 8) Investigators believe that other patients are not suitable for VR training.

Design outcomes

Primary

MeasureTime frame
MCCB general score;

Secondary

MeasureTime frame
MCCB factor score;VR software parameter score;

Countries

China

Contacts

Public ContactYi Xu

First Affiliated Hospital, Zhejiang University School of Medicine

xuyizju@163.com+86 13805746579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026